Proteostasis Failure in Neurodegenerative Diseases: Focus on Oxidative Stress

被引:106
|
作者
Hoehn, Annika [1 ,2 ]
Tramutola, Antonella [3 ]
Cascella, Roberta [4 ]
机构
[1] German Inst Human Nutr Potsdam Rehbruecke DIfE, Dept Mol Toxicol, Nuthetal, Germany
[2] German Ctr Diabet Res DZD, Neuherberg, Germany
[3] Sapienza Univ Rome, Dept Biochem Sci, Rome, Italy
[4] Univ Florence, Sect Biochem, Dept Expt & Clin Biomed Sci, Florence, Italy
关键词
UBIQUITIN-PROTEASOME SYSTEM; AMYLOID-BETA-PEPTIDE; FRONTOTEMPORAL LOBAR DEGENERATION; ALPHA-SYNUCLEIN OLIGOMERS; MULTICATALYTIC PROTEINASE COMPLEX; ENDOPLASMIC-RETICULUM STRESS; FAMILIAL ALZHEIMERS-DISEASE; MILD COGNITIVE IMPAIRMENT; LIPID-PEROXIDATION; OXIDIZED PROTEINS;
D O I
10.1155/2020/5497046
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Protein homeostasis or proteostasis is an essential balance of cellular protein levels mediated through an extensive network of biochemical pathways that regulate different steps of the protein quality control, from the synthesis to the degradation. All proteins in a cell continuously turn over, contributing to development, differentiation, and aging. Due to the multiple interactions and connections of proteostasis pathways, exposure to stress conditions may cause various types of protein damage, altering cellular homeostasis and disrupting the entire network with additional cellular stress. Furthermore, protein misfolding and/or alterations during protein synthesis results in inactive or toxic proteins, which may overload the degradation mechanisms. The maintenance of a balanced proteome, preventing the formation of impaired proteins, is accomplished by two major catabolic routes: the ubiquitin proteasomal system (UPS) and the autophagy-lysosomal system. The proteostasis network is particularly important in nondividing, long-lived cells, such as neurons, as its failure is implicated with the development of neurodegenerative diseases, such as Alzheimer's disease, Parkinson's disease, and amyotrophic lateral sclerosis. These neurological disorders share common risk factors such as aging, oxidative stress, environmental stress, and protein dysfunction, all of which alter cellular proteostasis, suggesting that general mechanisms controlling proteostasis may underlay the etiology of these diseases. In this review, we describe the major pathways of cellular proteostasis and discuss how their disruption contributes to the onset and progression of neurodegenerative diseases, focusing on the role of oxidative stress.
引用
收藏
页数:21
相关论文
共 50 条
  • [1] Insights into the Pathogenesis of Neurodegenerative Diseases: Focus on Mitochondrial Dysfunction and Oxidative Stress
    Jurcau, Anamaria
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (21)
  • [2] Neurodegenerative diseases and oxidative stress
    Kevin J. Barnham
    Colin L. Masters
    Ashley I. Bush
    Nature Reviews Drug Discovery, 2004, 3 : 205 - 214
  • [3] Oxidative stress in neurodegenerative diseases
    Chen, Xueping
    Guo, Chunyan
    Kong, Jiming
    NEURAL REGENERATION RESEARCH, 2012, 7 (05) : 376 - 385
  • [4] Oxidative stress in neurodegenerative diseases
    Aslan, M
    Özben, T
    FRONTIERS IN NEURODEGENERATIVE DISORDERS AND AGING: FUNDAMENTAL ASPECTS, CLINICAL PERSPECTIVES AND NEW INSIGHTS, 2004, 358 : 158 - 169
  • [5] Oxidative Stress in Neurodegenerative Diseases
    Niedzielska, Ewa
    Smaga, Irena
    Gawlik, Maciej
    Moniczewski, Andrzej
    Stankowicz, Piotr
    Pera, Joanna
    Filip, Magorzata
    MOLECULAR NEUROBIOLOGY, 2016, 53 (06) : 4094 - 4125
  • [6] Oxidative stress in neurodegenerative diseases
    Xueping Chen1
    Neural Regeneration Research, 2012, 7 (05) : 376 - 385
  • [7] Oxidative Stress in Neurodegenerative Diseases
    Domanskyi, Andrii
    Parlato, Rosanna
    ANTIOXIDANTS, 2022, 11 (03)
  • [8] Oxidative Stress in Neurodegenerative Diseases
    Ewa Niedzielska
    Irena Smaga
    Maciej Gawlik
    Andrzej Moniczewski
    Piotr Stankowicz
    Joanna Pera
    Małgorzata Filip
    Molecular Neurobiology, 2016, 53 : 4094 - 4125
  • [9] Neurodegenerative diseases and oxidative stress
    Emerit, J
    Edeas, A
    Bricaire, F
    BIOMEDICINE & PHARMACOTHERAPY, 2004, 58 (01) : 39 - 46
  • [10] Oxidative stress in neurodegenerative diseases
    Simonian, NA
    Coyle, JT
    ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 1996, 36 : 83 - 106